Propecia 3rd Q sales are down 7% from the 3rd Q of 2011-- 104 million to 112 million
Propecia YTD sales are down 5% from 312 million in 2012-- 330 million in 2011
Proscar 3rd Q sales are down 6% from the 3rd Q of 2011–55 million to 58 million
Proscar YTD sales are down 6% from 2011 160 million in 2012–171 million in 2011